Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $125
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Jon Young maintains a Buy rating on Merit Medical Systems (NASDAQ:MMSI) and raises the price target from $102 to $125.
July 02, 2024 | 5:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Canaccord Genuity analyst Jon Young maintains a Buy rating on Merit Medical Systems and raises the price target from $102 to $125.
The raised price target from $102 to $125 by a reputable analyst suggests increased confidence in the company's future performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100